secwatch.observer — SEC 8-K summary
======================================

Issuer:     JOHNSON & JOHNSON (JNJ)
CIK:        0000200406
Form:       8-K
Filed at:   2023-01-24T23:59:59+00:00
Accession:  0000200406-23-000005
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

J&J Q4 sales fall 4.4% to $23.7B; adjusted EPS rises 10.3% to $2.35; 2023 guidance issued
--------------------------------------------------------------------------------

- Q4 reported sales $23.7B, -4.4% YoY; operational growth ex-COVID vaccine +4.6%.
- Q4 GAAP EPS $1.33 (down 24.9%); adjusted EPS $2.35 (+10.3%).
- Full-year 2022 sales $94.9B (+1.3% reported); operational growth 6.1%.
- FY2022 GAAP EPS $6.73 (-13.8%); adjusted EPS $10.15 (+3.6%).
- 2023 guidance: adj. operational sales growth ex-COVID vaccine +4.0%; adj. EPS ~$10.50 (+3.5%).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/200406/000020040623000005/0000200406-23-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/200406/000020040623000005/jnj-20230124.htm
  HTML page:      https://secwatch.observer/filing/0000200406-23-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer